Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2008

01-12-2008 | Research Article

Dispensing of psychotropic drugs to adults in community pharmacies in Latvia

Authors: Kristine Vrublevska, Jurita Rukmane, Rihards Burmistrs, Janis Sipols, Ruta Muceniece

Published in: International Journal of Clinical Pharmacy | Issue 6/2008

Login to get access

Abstract

Objective To estimate outpatient utilization of psychotropic drugs before and after pharmaceutical reform in Latvia. Setting Data concerning prescribing and dispensing of psychotropic drugs were collected in six community pharmacies in the region of Latgale of Latvia. Method An exploratory analysis of prescription data provided by six community pharmacies from 2004 to 2007. Drugs included in the study were classified according to an Anatomical–Therapeutic–Chemical (ATC) drug classification system, and ATC data were used to calculate defined daily doses (DDD) per 1,000 inhabitants. The National SSK-10 classification was used for analysis of codes of disease diagnosis. Main outcome measures Identification of the most often prescribed psychotropic drug and prescribing physician, patient characterization by age and gender, and analysis of codes of diseases. Results Benzodiazepines and benzodiazepine-related drugs were mainly prescribed in outpatient practice. Diazepam was the most frequently prescribed benzodiazepine-12 DDD/1,000/day. The drugs were prescribed mainly by family physicians (in 66% of cases). Female residents bought more psychotropic drugs than males. In addition, residents of cities bought little more drugs than those living outside urban areas. Accordingly to the recorded disease codes, the codes for neurotic and behavioral disorders dominated. Conclusion The introduction of new norms neither increased nor decreased the number of psychotropic drug prescriptions filled. The most often prescribed psychotropic drugs over 4-year period were benzodiazepines and their derivates. Disease codes on the prescriptions fully justified a reason for psychotropic drug use.
Literature
3.
go back to reference Montanaro N, Magrini N, Vaccheri A, Battilan M. Drug utilization in general practice: prescribing habits of national formulary drugs by CPs of Emilia Romagna (Italy) in 1988 and 1989. Eur J Clin Pharmacol. 1992;42:401–8.PubMed Montanaro N, Magrini N, Vaccheri A, Battilan M. Drug utilization in general practice: prescribing habits of national formulary drugs by CPs of Emilia Romagna (Italy) in 1988 and 1989. Eur J Clin Pharmacol. 1992;42:401–8.PubMed
4.
go back to reference Shapiro S. The epidemiological evaluation of drugs. Acta Med Scand. 1982;Suppl 683:23–7. Shapiro S. The epidemiological evaluation of drugs. Acta Med Scand. 1982;Suppl 683:23–7.
5.
go back to reference Bergman U. Pharmacoepidemiology—from description to quality assessment. A Swedish perspective. Nor J Epidemiol. 2001;11:31–6. Bergman U. Pharmacoepidemiology—from description to quality assessment. A Swedish perspective. Nor J Epidemiol. 2001;11:31–6.
7.
go back to reference Guidelines for ATC classification and DDD assignment 2003 6th ed. World Health Organization Collaborating Centre for Drug Statistics Methodology. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology, 2002. ISBN 8280820256. Guidelines for ATC classification and DDD assignment 2003 6th ed. World Health Organization Collaborating Centre for Drug Statistics Methodology. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology, 2002. ISBN 8280820256.
8.
go back to reference Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm. 1986;21(3):233–4. 239–41, 258.PubMed Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm. 1986;21(3):233–4. 239–41, 258.PubMed
9.
go back to reference Sacristan JA, Soto J. Drug utilisation studies as tools in health economics. Pharmacoeconomics. 1994;5:299–312.PubMedCrossRef Sacristan JA, Soto J. Drug utilisation studies as tools in health economics. Pharmacoeconomics. 1994;5:299–312.PubMedCrossRef
10.
go back to reference Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002;63:817–25.PubMed Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002;63:817–25.PubMed
11.
go back to reference Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109(s420):55–64. doi:10.1111/j.1600-0047.2004.00325.x.CrossRef Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109(s420):55–64. doi:10.​1111/​j.​1600-0047.​2004.​00325.​x.CrossRef
13.
go back to reference van Hulten R, Isacson D, Bakker A, Leufkens HG. Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf. 2003;12(1):49–53. doi:10.1002/pds.784.PubMedCrossRef van Hulten R, Isacson D, Bakker A, Leufkens HG. Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol Drug Saf. 2003;12(1):49–53. doi:10.​1002/​pds.​784.PubMedCrossRef
14.
15.
go back to reference Divac N, Jasović M, Djukić L, Vujnović M, Babić D, Bajcetić M, et al. Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol Drug Saf. 2004;13(5):315–22. doi:10.1002/pds.940.PubMedCrossRef Divac N, Jasović M, Djukić L, Vujnović M, Babić D, Bajcetić M, et al. Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia. Pharmacoepidemiol Drug Saf. 2004;13(5):315–22. doi:10.​1002/​pds.​940.PubMedCrossRef
17.
go back to reference Paakari P, Voipio T. The growing consumption of hypnotics and sedatives evens out. Natl Agency Medicines TABU. 2005;3:37–9. Paakari P, Voipio T. The growing consumption of hypnotics and sedatives evens out. Natl Agency Medicines TABU. 2005;3:37–9.
18.
20.
go back to reference Mirandola M, Andretta M, Corbari L, Sorio A, Nosè M, Barbui C. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999–2002. Pharmacoepidemiol Drug Saf. 2006;15(6):412–20. doi:10.1002/pds.1162.PubMedCrossRef Mirandola M, Andretta M, Corbari L, Sorio A, Nosè M, Barbui C. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999–2002. Pharmacoepidemiol Drug Saf. 2006;15(6):412–20. doi:10.​1002/​pds.​1162.PubMedCrossRef
22.
go back to reference Bachmann CS, Berg EA, Spigset O, Slørdal L. Benzodiazepine-like hypnotics—attitudes and prescription practice among general practioners. Tidsskr Nor Laegeforen. 2008;128(2):166–70.PubMed Bachmann CS, Berg EA, Spigset O, Slørdal L. Benzodiazepine-like hypnotics—attitudes and prescription practice among general practioners. Tidsskr Nor Laegeforen. 2008;128(2):166–70.PubMed
Metadata
Title
Dispensing of psychotropic drugs to adults in community pharmacies in Latvia
Authors
Kristine Vrublevska
Jurita Rukmane
Rihards Burmistrs
Janis Sipols
Ruta Muceniece
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-008-9256-x

Other articles of this Issue 6/2008

International Journal of Clinical Pharmacy 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.